查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511793

粒子束治疗市场规模、份额、趋势分析报告：按治疗类型、系统、应用、癌症类型、地区、细分市场预测，2024-2030

Particle Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Proton Therapy, Heavy Ion Therapy), By System, By Application (Treatment, Research), By Cancer Type (Pediatric, Breast, Lung), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

粒子束治疗市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球粒子治疗市场规模将达到25.5亿美元，2024年至2030年复合年增长率为7.63%。

市场成长的主要原因是由于老年人口的增加而导致癌症盛行率的增加。这种疾病可以在任何年龄发生，但随着年龄的增长，发生这种疾病的可能性会显着增加。根据 GLOBOCAN 2022资料，约 53% 的癌症患者年龄超过 65 岁。这种相关性可能是由于细胞修復过程效率较低以及某些恶性危险因子的累积造成的，这些危险因子随着老龄化的增长而增加。

因此，为了确保老年人在追求全民健康覆盖的过程中不被抛在后面，各国政府需要製定计划来促进患有癌症的老年人的改变。政府增加对癌症患者及其看护者完成治疗的支持将推动市场成长。例如，2024年4月，阿尔巴尼亚政府将提供16.5美元的癌症支持计画津贴，第一轮申请现已开放。该计划将改善澳洲各地个人的疾病结果。这笔津贴旨在支持全国各地促进护理的小型组织。此外，国际癌症控制联盟（UICC）将每年的2月4日定为世界癌症日，以提高人们对癌症及其治疗方法的认识。

预计此类倡议将在预测期内推动粒子治疗的需求并推动市场成长。计算技术的进步正在带来更快、更聪明、更有效的治疗计划，从而实现持续的影像导引、更精确的剂量和更高的剂量。其结果是提高了效率并减少了副作用。先进的电脑演算法促进了剂量优化和治疗计划。质子治疗的出现有助于克服患者运动（例如呼吸时）引起的问题。此外，雷射技术的进步使得超快双光脉衝的开发成为可能，这些脉衝可以与亚原子过程相互作用，有助于使用同步加速器辐射追踪超快原子内运动。

此外，疾病诊断和治疗中心的推出也支持了预测期内的产品需求。例如，2023年2月，阿波罗质子癌症中心推出了名为「Dr. APJ Abdul Kalam Therapy Bay」的质子束龙门，提供印度最先进的综合癌症治疗。该医院开展全国最大的质子束治疗 (PBT) 计画来治疗患者。 APCC 是中东和南亚第一家也是唯一一家质子治疗中心。

粒子治疗市场报告亮点

  • 由于治疗率高、副作用减少、治疗持续率高以及盛行率增加，质子治疗领域在 2023 年占据最大份额。
  • 单房间系统部分预计在预测期内将以最快的复合年增长率增长，因为它比多房间系统具有优势，例如成本更低，小型医院和设施的采用率不断提高。
  • 由于住院治疗率增加、患者更喜欢粒子束治疗而不是其他方法以及到医院接受治疗的患者数量增加，治疗领域在 2023 年占据最大份额。
  • 由于全球盛行率和发病率不断上升，以及粒子疗法治疗的需求不断增长，2023年小儿癌症领域将占据最大份额。
  • 由于先进的医疗基础设施、高盛行率和有利的法规环境等因素，北美在 2023 年将主导全球市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章粒子治疗市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 粒子束治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章 粒子束治疗市场：治疗评估与趋势分析

  • 全球粒子治疗市场：按治疗类型分類的仪表板
  • 全球粒子束治疗市场：按治疗类型分類的波动分析
  • 全球粒子治疗市场：按治疗类型和收益
  • 质子治疗
  • 重粒子线治疗

第五章 粒子束治疗市场：系统估计与趋势分析

  • 全球粒子治疗市场：按系统分類的仪表板
  • 全球粒子束治疗市场：依系统进行变化分析
  • 全球粒子束治疗市场：按系统和收益
  • 单间系统
  • 多房间系统

第六章 粒子束治疗市场：应用估算与趋势分析

  • 全球粒子束治疗市场：按应用分類的仪表板
  • 全球粒子束治疗市场：按应用分析波动
  • 全球粒子束治疗市场：按应用和收益
  • 治疗
  • 临床调查

第七章 粒子治疗市场：癌症类型估算及趋势分析

  • 全球粒子治疗市场：按癌症类型分類的仪表板
  • 全球粒子束治疗市场：按癌症类型的波动分析
  • 全球粒子束治疗市场：按癌症类型和收益
  • 儿童癌症
  • 乳癌
  • 肺癌
  • 头颈癌
  • 其他的

第八章 粒子治疗市场：按治疗类型、系统和应用分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争格局

  • 公司/竞争对手分类
  • 参与者概览
  • 财务概览
  • 产品基准
  • 2023 年企业市场占有率分析
  • 策略规划
  • 公司简介
    • IBA Worldwide.
    • Siemens Healthcare GmbH（Varian Medical Systems, Inc.）
    • Hitachi Ltd
    • Mevion Medical Systems.
    • Provision Healthcare.
    • Optivus Proton Therapy, Inc.
    • Sumitomo Heavy Industries, Ltd.
    • ProTom International.
    • B dot Medical Inc.
    • LeyBold.
    • Advanced Oncotherapy Plc.
Product Code: GVR-4-68040-289-2

Particle Therapy Market Growth & Trends:

The global particle therapy market size is anticipated to reach USD 2.55 billion by 2030, registering a CAGR of 7.63% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is primarily driven by the increasing prevalence of cancer aided by the growing geriatric population. Any age can acquire the disease, but as people age, their chances of developing the disease increase significantly. According to GLOBOCAN 2022 data, approximately 53% of cancer patients were aged 65 years or older. This correlation is probably caused by less efficient cellular repair processes and the build-up of risk factors for particular malignancies, which rise with age.

Therefore, to ensure that older adults are not left behind in the pursuit of universal health coverage, governments will need to devise a plan to promote change for older adults with cancer. Increasing government support for cancer patients and their caregivers for treatment completion fuels the market's growth. For instance, in April 2024, the Albanese Government offered USD 16.5 for a Cancer Support Program grant, with the first round now open for application. This program will enhance disease outcomes for individuals all across Australia. The funding is intended to support small national organizations that promote treatment. Furthermore, the Union for International Cancer Control (UICC) celebrates 4th February as "World Cancer Day" every year to raise awareness about cancer and available options for treatment.

Such initiatives are expected to drive demand for particle beam treatment over the forecast period, driving market growth. Technological advancements in computing have resulted in faster, more intelligent, & more capable treatment planning and have enabled constant imaging guidance, more precise dosing, and delivery of higher doses. This has resulted in greater efficiency & fewer adverse effects. Dosage optimization and treatment planning have become easier owing to advanced computer algorithms. The advent of proton radiation therapy has helped overcome problems due to the movement of patients, such as during breathing. Furthermore, advances in laser technology enable the development of ultra-quick double-light pulses that can interact with the subatomic process, which helps in tracking ultrafast intra-atom motion using synchrotron radiation.

Moreover, the growing launch of disease diagnosis and treatment centers drives demand for products during the forecast period. For instance, in February 2023, the Apollo Proton Cancer Center launched a Proton Gantry named "Dr. APJ Abdul Kalam Therapy Bay" to offer the most advanced and comprehensive cancer care in India. The hospital administers the nation's largest Proton Beam Therapy (PBT) program to treat patients. APCC is the first and only proton therapy center in the Middle East and South Asia.

Particle Therapy Market Report Highlights:

  • The proton therapy segment held the largest share in 2023 due to the disease's high treatment rate, decreased side effects, high treatment adherence rate, and growing prevalence
  • The single-room systems segment is expected to grow at the fastest CAGR during the forecast period due to its advantages over multi-room systems, such as low cost, and increased adoption by smaller hospitals and facilities
  • The treatment segment held the largest share in 2023 due to hospital treatment rates, patient preference for particle therapy over other methods, and an increasing number of patients visiting hospitals for treatment
  • The pediatric cancer segment held the largest in 2023 owing to a rise in the prevalence and incidence of the disease worldwide and rising demand for particle therapy for its treatment
  • North America dominated the global market in 2023 owing to factors advanced healthcare infrastructure, high disease prevalence, and a favorable regulatory environment

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Therapy Type
    • 1.2.2. System
    • 1.2.3. Application
    • 1.2.4. Cancer Type
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Therapy type and system Outlook
    • 2.2.2. Application and cancer type outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Particle Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of cancer
      • 3.2.1.2. Increasing awareness about benefits of particle therapy
      • 3.2.1.3. Rising geriatric population
      • 3.2.1.4. Technological advancements in particle therapy
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of skilled radiotherapy professionals
      • 3.2.2.2. Stringent regulatory policies
      • 3.2.2.3. Adverse effects of particle therapy
  • 3.3. Particle Therapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Particle Therapy Market: Therapy Estimates & Trend Analysis

  • 4.1. Global Particle Therapy Market: Therapy Type Dashboard
  • 4.2. Global Particle Therapy Market: Therapy Type Movement Analysis
  • 4.3. Global Particle Therapy Market By Therapy Type, Revenue
  • 4.4. Proton Therapy
    • 4.4.1. Proton Therapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Heavy Ion Therapy
    • 4.5.1. Heavy Ion Therapy market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Particle Therapy Market: System Estimates & Trend Analysis

  • 5.1. Global Particle Therapy Market: System Dashboard
  • 5.2. Global Particle Therapy Market: System Movement Analysis
  • 5.3. Global Particle Therapy Market By System, Revenue
  • 5.4. Single Room Systems
    • 5.4.1. Single room systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Multi-room Systems
    • 5.5.1. Multi-room systems market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Particle Therapy Market: Application Estimates & Trend Analysis

  • 6.1. Global Particle Therapy Market: Application Dashboard
  • 6.2. Global Particle Therapy Market: Application Movement Analysis
  • 6.3. Global Particle Therapy Market By Application, Revenue
  • 6.4. Treatment
    • 6.4.1. Treatment market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Clinical Research
    • 6.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Particle Therapy Market: Cancer Type Estimates & Trend Analysis

  • 7.1. Global Particle Therapy Market: Cancer Type Dashboard
  • 7.2. Global Particle Therapy Market: Cancer Type Movement Analysis
  • 7.3. Global Particle Therapy Market By Cancer Type, Revenue
  • 7.4. Pediatric Cancer
    • 7.4.1. Pediatric cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Breast Cancer
    • 7.5.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Lung Cancer
    • 7.6.1. Lung cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Head and Neck Cancer
    • 7.7.1. Head and neck cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Particle Therapy Market: Regional Estimates & Trend Analysis By Therapy Type, System, and Application

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Participant Overview
  • 9.3. Financial Overview
  • 9.4. Product Benchmarking
  • 9.5. Company Market Share Analysis, 2023
  • 9.6. Strategy Mapping
  • 9.7. Company Profiles
    • 9.7.1. IBA Worldwide.
      • 9.7.1.1. Company overview
      • 9.7.1.2. Financial performance
      • 9.7.1.3. benchmarking
      • 9.7.1.4. Strategic initiatives
    • 9.7.2. Siemens Healthcare GmbH (Varian Medical Systems, Inc.)
      • 9.7.2.1. Company overview
      • 9.7.2.2. Financial performance
      • 9.7.2.3. benchmarking
      • 9.7.2.4. Strategic initiatives
    • 9.7.3. Hitachi Ltd
      • 9.7.3.1. Company overview
      • 9.7.3.2. Financial performance
      • 9.7.3.3. benchmarking
      • 9.7.3.4. Strategic initiatives
    • 9.7.4. Mevion Medical Systems.
      • 9.7.4.1. Company overview
      • 9.7.4.2. Financial performance
      • 9.7.4.3. benchmarking
      • 9.7.4.4. Strategic initiatives
    • 9.7.5. Provision Healthcare.
      • 9.7.5.1. Company overview
      • 9.7.5.2. Financial performance
      • 9.7.5.3. benchmarking
      • 9.7.5.4. Strategic initiatives
    • 9.7.6. Optivus Proton Therapy, Inc.
      • 9.7.6.1. Company overview
      • 9.7.6.2. Financial performance
      • 9.7.6.3. benchmarking
      • 9.7.6.4. Strategic initiatives
    • 9.7.7. Sumitomo Heavy Industries, Ltd.
      • 9.7.7.1. Company overview
      • 9.7.7.2. Financial performance
      • 9.7.7.3. benchmarking
      • 9.7.7.4. Strategic initiatives
    • 9.7.8. ProTom International.
      • 9.7.8.1. Company overview
      • 9.7.8.2. Financial performance
      • 9.7.8.3. benchmarking
      • 9.7.8.4. Strategic initiatives
    • 9.7.9. B dot Medical Inc.
      • 9.7.9.1. Company overview
      • 9.7.9.2. Financial performance
      • 9.7.9.3. benchmarking
      • 9.7.9.4. Strategic initiatives
    • 9.7.10. LeyBold.
      • 9.7.10.1. Company overview
      • 9.7.10.2. Financial performance
      • 9.7.10.3. benchmarking
      • 9.7.10.4. Strategic initiatives
    • 9.7.11. Advanced Oncotherapy Plc.
      • 9.7.11.1. Company overview
      • 9.7.11.2. Financial performance
      • 9.7.11.3. benchmarking
      • 9.7.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America particle therapy market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 4 North America particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 5 North America particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 6 U.S. particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 7 U.S. particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 8 U.S. particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 9 U.S. particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 10 Canada particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 11 Canada particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 12 Canada particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 13 Canada particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 14 Europe particle therapy market, by region, 2018 - 2030 (USD Million)
  • Table 15 Europe particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 16 Europe particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 17 Europe particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 18 Europe particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 19 Germany particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 20 Germany particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 21 Germany particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 22 Germany particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 23 UK particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 24 UK particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 25 UK particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 26 UK particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 27 France particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 28 France particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 29 France particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 30 France particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 31 Italy particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 32 Italy particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 33 Italy particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 34 Italy particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 35 Spain particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 36 Spain particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 37 Spain particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 38 Spain particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 39 Denmark particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 40 Denmark particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 41 Denmark particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 42 Denmark particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 43 Sweden particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 44 Sweden particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 45 Sweden particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 46 Sweden particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 47 Norway particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 48 Norway particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 49 Norway particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 50 Norway particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific particle therapy market, by region, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 54 Aisa Pacific particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 56 China particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 57 China particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 58 China particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 59 China particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 60 Japan particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 61 Japan particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 62 Japan particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 63 Japan particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 64 India particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 65 India particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 66 India particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 67 India particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 68 South Korea particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 69 South Korea particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 70 South Korea particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 71 South Korea particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 72 Australia particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 73 Australia particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 74 Australia particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 75 Australia particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 76 Thailand particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 77 Thailand particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 78 Thailand particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 79 Thailand particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 80 Latin America particle therapy market, by region, 2018 - 2030 (USD Million)
  • Table 81 Latin America particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 82 Latin America particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 83 Latin America particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 84 Latin America particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 85 Brazil particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 86 Brazil particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 87 Brazil particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 88 Brazil particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 89 Mexico particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 90 Mexico particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 91 Mexico particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 92 Mexico particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 93 Argentina particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 94 Argentina particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 95 Argentina particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 96 Argentina particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 97 MEA particle therapy market, by region, 2018 - 2030 (USD Million)
  • Table 98 MEA particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 99 MEA particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 100 MEA particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 101 MEA particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 102 South Africa particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 103 South Africa particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 104 South Africa particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 105 South Africa particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 110 UAE particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 111 UAE particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 112 UAE particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 113 UAE particle therapy market, By cancer type, 2018 - 2030 (USD Million)
  • Table 114 Kuwait particle therapy market, By therapy type, 2018 - 2030 (USD Million)
  • Table 115 Kuwait particle therapy market, By system, 2018 - 2030 (USD Million)
  • Table 116 Kuwait particle therapy market, By application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait particle therapy market, By cancer type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Particle therapy market: market outlook
  • Fig. 14 Particle therapy competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Particle therapy market driver impact
  • Fig. 18 Particle therapy market restraint impact
  • Fig. 19 Particle therapy market: Therapy type movement analysis
  • Fig. 20 Particle therapy market: Therapy type outlook and key takeaways
  • Fig. 21 Proton Therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Heavy Ion Therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Particle therapy market: System movement analysis
  • Fig. 24 Particle therapy market: System outlook and key takeaways
  • Fig. 25 Single room systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Multi-room systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Particle therapy market: Application movement analysis
  • Fig. 28 Particle therapy market: Application outlook and key takeaways
  • Fig. 29 Treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Clinical research estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Particle therapy market: Cancer type movement analysis
  • Fig. 32 Particle therapy market: Cancer type outlook and key takeaways
  • Fig. 33 Pediatric cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Pediatric cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Head and neck cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Global particle therapy market: Regional movement analysis
  • Fig. 40 Global particle therapy market: Regional outlook and key takeaways
  • Fig. 41 Global particle therapy market share and leading players
  • Fig. 42 North America, by country
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. key country dynamics
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Canada key country dynamics
  • Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK key country dynamics
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Germany key country dynamics
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France key country dynamics
  • Fig. 54 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Italy key country dynamics
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Spain key country dynamics
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Sweden key country dynamics
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Norway key country dynamics
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 China key country dynamics
  • Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 India key country dynamics
  • Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand key country dynamics
  • Fig. 73 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Korea key country dynamics
  • Fig. 75 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Australia key country dynamics
  • Fig. 77 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Brazil key country dynamics
  • Fig. 80 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Mexico key country dynamics
  • Fig. 82 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Argentina key country dynamics
  • Fig. 84 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa key country dynamics
  • Fig. 87 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia key country dynamics
  • Fig. 89 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 UAE key country dynamics
  • Fig. 91 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Kuwait key country dynamics
  • Fig. 93 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Market share of key market players- particle therapy market